Public-registry site landscape for NCT07739199, a Squamous Non-small-cell Lung Cancer study sponsored by Sichuan Baili Pharmaceutical Co., Ltd.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07739199 (registry record) |
| Sponsor | Sichuan Baili Pharmaceutical Co., Ltd. |
| Condition(s) | Squamous Non-small-cell Lung Cancer |
| Phase | PHASE2 / PHASE3 |
| Listed sites | 2 |
| Site countries | China |
At Sun Yat-sen University Cancer Center — one of the facilities listed on this trial — 9 other studies are actively recruiting Squamous Non-small-cell Lung Cancer patients at the same facility (public registry, as of July 2026). Facility-level recruiting density is one of the strongest public correlates of enrollment pace in an indication.
Eichor generates a preliminary site-risk snapshot for NCT07739199 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →